Relationship between XRCC1 and XPD polymorphisms and the risk of the development of hepatocellular carcinoma: A case-control study

Experimental and Therapeutic Medicine

Volumn 4, Issue 2, 2012, Pages 285-290

  Yuan, Tao ^a   Deng, Shaoli ^a   Liu, Hongming ^a   Liu, Menggang ^a   Chen, Ping ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Genotype; Hepatocellular carcinoma; Polymorphisms; Susceptibility

Indexed keywords

XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE COURSE; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; RISK; SMOKING;

EID: 84862657676     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.581     Document Type: Article

References (24)

1. Silvestri L, Sonzogni L, De Silvestri A, et al: CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. Int J Cancer 104: 310-317, 2003.
2. Kirk GD, Lesi OA, Mendy M, et al: 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. Oncogene 24: 5858-5867, 2005.
3. Hara A, Sakata K, Yamada Y, et al: Suppression of β-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N,N-diethylnitrosamine-induced hepatocellular carcinomas in rats. Oncol Rep 14: 345-351, 2005.
4. Marrero JA, Fontana RJ, Fu S, et al: Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42: 218-224, 2005.
5. Zhang X, Miao X, Liang G, et al: Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res 65: 722-726, 2005.
6. Gerlitz G: HMGNs. DNA repair and cancer. Biochim Biophys Acta 1799: 80-85, 2010.
7. Song DK, Xing DL, Zhang LR, et al: Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China. Cancer Detect Prev 32: 416-423, 2009.
8. Ginsberg G, Angle K, Guyton K and Sonawane B: Polymorphism in the DNA repair enzyme XRCC1: Utility of current database and implications for human health risk assessment. Mutat Res 727: 13-15, 2011.
9. Lindahl T and Wood RD: Quality control by DNA repair. Science 286: 1897-1905, 1999.
10. Shen MR, Jones LM and Mohrenweiser H: Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58: 604-608, 1998.
11. Xing D, Qi J, Miao X, et al: Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int J Cancer 100: 600-605, 2002.
12. Lee SG, Kim B, Choi J, et al: Genetic polymorphisms of XRCC1 and risk of gastric cancer. Cancer Lett 187: 53-60, 2002.
13. Park JY, Lee SY, Jeon HS, et al: Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 11: 23-27, 2002.
14. Kim SU, Park SK, Yoo KY, et al: XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics 12: 335-338, 2002.
15. Au WW, Salama SA and Sierra-Torres CH: Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect 111: 1843-1850, 2003.
16. Liang G, Xing D, Miao XD, et al: Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population. Int J Cancer 105: 669-673, 2003.
17. Abdel-Rahman SZ, Soliman AS, Bondy ML, et al: Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett 159: 79-86, 2000.
18. David-Beabes GL and London SJ: Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians. Lung Cancer 34: 333-339, 2001.
19. Lunn RM, Langlois RG, Hsieh LL, et al: XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59: 2557-2561, 1999.
20. Kiran M, Saxena R, Chawla YK, et al: Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol Cell Biochem 327: 7-13, 2009.
21. Cheng L, Spitz MR, Hong WK, Wei Q: Reduced expression levels of nucleotide excision repair genes in lung cancer. Carcinogenesis 21: 1527-1530, 2000.
22. Vogel U, Nexø BA, Tjønneland A, et al: ERCC1, XPD and RAI mRNA levels in lymphocytes are not associated with lung cancer risk in a prospective study of Danes. Mutat Res 593: 88-96, 2006.
23. Long XD, Ma Y, Zhou YF, et al: XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk. BMC Cancer 17: 400, 2009.
24. Long XD, Ma Y, Wei YP, et al: The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatol Res 36: 48-55, 2006.